Dx & Vx Co., Ltd. (KOSDAQ:180400)
South Korea · Delayed Price · Currency is KRW 2,630.00
+150.00 (6.05%)
At close: Aug 24, 2026
Dx & Vx Market Cap
Dx & Vx has a market cap or net worth of 244.1 billion as of August 21, 2026. Its market cap has increased by 87.15% in one year.
Market Cap
244.10B
Enterprise Value
196.97B
Revenue
28.48B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,630.00
ChartMarket Cap Chart
Since November 20, 2015, Dx & Vx's market cap has increased from 75.32B to 244.10B, an increase of 224.11%. That is a compound annual growth rate of 11.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 244.10B | 57.95% |
| Dec 30, 2025 | 154.55B | 68.91% |
| Dec 30, 2024 | 91.50B | -48.77% |
| Dec 28, 2023 | 178.59B | 52.96% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3billion | 183.93B |
| GENINUS | 78.78B |
| Cytogen | 78.32B |
| Protia | 61.57B |
| Inventera | 58.21B |
| GC Medical Science | 56.75B |
| HLB Panagene | 51.58B |
| Seoulin Bioscience | 38.20B |